Study design and population:
Between July 2020 and October 2021, 8 patients underwent concomitant Anaortic OPCAB and transfemoral TAVR during the same anesthetic. All patients had severe aortic stenosis noted on pre-operative echocardiographic evaluation, as defined by the AHA guidelines, and concomitant coronary disease that was considered not amenable to PCI. Furthermore, significant aortic calcification and atheromatous disease were also seen in all 8 patients with all patients being diagnosed with a porcelain aorta prior to surgical intervention (Table 1). Patients were evaluated by the institutional, multidisciplinary structural heart team including cardiac surgeons, imaging and interventional cardiologists. Once approved, the patients were scheduled for concomitant anaortic OPCAB and TAVR.